Filing Details
- Accession Number:
- 0001127602-12-026850
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-21 18:24:05
- Reporting Period:
- 2012-09-20
- Filing Date:
- 2012-09-21
- Accepted Time:
- 2012-09-21 17:24:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1231589 | A Paul Mahon | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Evp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-09-20 | 6,000 | $25.32 | 39,600 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-09-20 | 6,000 | $58.05 | 33,600 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Share Tracking Award | Disposition | 2012-09-20 | 6,000 | $0.00 | 6,000 | $25.32 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
47,749 | 2009-06-03 | 2018-06-03 | No | 4 | M | Direct |
Footnotes
- Exercise of a cash-settled share tracking award.
- This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.